Insider Transactions in Q2 2025 at Terns Pharmaceuticals, Inc. (TERN)
Insider Transaction List (Q2 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 27
2025
|
Andrew Gengos Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
10,000
+18.33%
|
$30,000
$3.93 P/Share
|
|
Jun 25
2025
|
Amy L. Burroughs Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
23,314
+33.12%
|
$69,942
$3.87 P/Share
|
|
Jun 16
2025
|
Andrew Gengos Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
5,000
+25.0%
|
$15,000
$3.95 P/Share
|
|
Jun 13
2025
|
Andrew Gengos Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
10,000
+41.67%
|
$30,000
$3.74 P/Share
|
|
Apr 01
2025
|
Emil Kuriakose Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
952
-1.75%
|
$1,904
$2.49 P/Share
|